The emergency rule comes just one day before a planned hearing between the DOH and the AIDS Healthcare Foundation.

Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at CROI 2026 showing a treatment switch to an investigational, single-tablet ...

Starting Sunday, the state will cut its subsidies for the AIDS ​Drug Assistance Program (ADAP), and funds will only be available for people at or below 130% of the federal poverty level, a drop from ...

The Florida Department of Health has issued emergency rules that could sharply restrict access to HIV medications for ...

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.

Kenya's health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection ...

The Global Fund has committed an additional Sh256 million ($2 million) to support Kenya’s rollout of the long-acting HIV ...

In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...

A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that can prevent HIV.

Bihar is launching a 17-day health camp initiative across all 38 districts to screen for HIV, aiming to identify undiagnosed cases and link individuals to treatment. This drive, targeting migrant ...